View
Page
"The licensing agreement for Southeast Europe is in line with the company’s regional licensing strategy and represents a further step towards global commercialisation of CSD500, the company’s novel erectogenic condom. We are looking forward to multiple launches of CSD500 by partners over the coming year." N+1 Singer note out this morning on Research Tree
Latest from the Community...
Latest from the Community...
Latest from the Community...